Authors:
Milpied, N
Vasseur, B
Parquet, N
Garnier, JL
Antoine, C
Quartier, P
Carret, AS
Bouscary, D
Faye, A
Bourbigot, B
Reguerre, Y
Stoppa, AM
Bourquard, P
de Ligny, BH
Dubief, F
Mathieu-Boue, A
Leblond, V
Citation: N. Milpied et al., Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients, ANN ONCOL, 11, 2000, pp. 113-116
Authors:
Lebranchu, Y
Aubert, P
Bayle, F
Bedrossian, J
Berthoux, F
Bourbigot, B
Buchler, M
Chalopin, JM
Deteix, P
Glotz, D
De Ligny, BH
Kessler, M
Lang, P
Lefrancois, N
Le Pogamp, P
Moulin, B
Mourad, G
Olmer, M
Sraer, JD
Touchard, G
Toupance, O
Wolf, P
Puget, S
Citation: Y. Lebranchu et al., Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids, TRANSPLAN P, 32(2), 2000, pp. 396-397